Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,622 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06549725Recruiting
Lipidica software for pancreatic cancer screening
This trial tests a software that analyzes fats (lipids) in your blood to find pancreatic cancer early. You may join if you have pancreatic cancer that can be removed with surgery, or if you are at very high risk due to family history or certain gene mutations.
Prague, CzechiaAges 18 years+ - NCT06550050Recruiting
Study of Mouth Precancer and Cancer Features
This study looks at tissue and blood samples from people with mouth conditions that could become cancer or are already cancer. It aims to learn more about these conditions to improve diagnosis and treatment.
Houston, TexasAges 18 years+ - NCT06550310Recruiting
Nutrition and IBD treatment outcomes
This study looks at how nutrition affects people with IBD who are starting a new treatment or having surgery. Researchers want to find out if diet or body changes influence how well you recover.
LondonAges 16 years+ - NCT06550713RecruitingPhase 1
Testing TQB3455 tablets for blood cancers with IDH2 mutation
This trial tests a new tablet, TQB3455, for people with certain blood cancers (MDS or AML) that have an IDH2 mutation. The goal is to see if the drug can help when other treatments haven't worked or aren't possible.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06551805Recruiting
Ferumoxytol for better MRI images in atherosclerosis patients
This study tests whether a special iron-based contrast agent called ferumoxytol can improve MRI images of arteries affected by atherosclerosis. It may help doctors see blockages or inflammation more clearly.
Nanjing, JiangsuAges 18 years+ - NCT06551844RecruitingPhase 2
Adaptive platform trial for new dengue treatments
This trial tests different experimental drugs to treat dengue early. It aims to find which treatment works best and is safe for patients who start within 48 hours of fever.
Kuala LumpurAges 10 years+ - NCT06552260RecruitingEarly Phase 1
Troriluzole before surgery for recurrent glioblastoma
This trial tests whether an investigational drug called troriluzole can help people with recurrent glioblastoma (a type of brain tumor). You would take the drug for a short time before your planned surgery, so researchers can study how the drug affects your tumor tissue. The goal is to see if it might slow tumor growth.
Boston, MassachusettsAges 18 years+ - NCT06553443RecruitingPhase 3
Comparing coated and plain balloons for dialysis access narrowing
This trial tests whether a drug-coated balloon works better than a plain balloon to open up narrowed spots in your dialysis access. If you have a failing AVF with a narrowing that can be treated, this study may help improve your dialysis.
SingaporeAges 21 years+ - NCT06553677Recruiting
Comparing two gum repair surgeries for receding gums
This study compares two surgical techniques to cover exposed tooth roots caused by receding gums. The goal is to see which method works better and helps your gums heal.
CairoAges 18 years+ - NCT06556667Recruiting
Comparing two cardioversion methods for persistent AFib
This trial compares two ways of doing cardioversion (a procedure to restore normal heart rhythm) for people with persistent atrial fibrillation. It aims to see if one approach leads to a better recovery and fewer complications.
Ottawa, OntarioAges 18 years+ - NCT06557161RecruitingPhase 2
Stem cell transplant with TBI or TMLI for adult ALL
This trial tests two different conditioning regimens (total body irradiation or total marrow/lymphoid irradiation) before a stem cell transplant from a matched sibling donor for adults with acute lymphoblastic leukemia (ALL) that is in remission. The goal is to see which regimen works better and has fewer side effects.
Zhengzhou, HenanAges 18–65 - NCT06557369Recruiting
New light therapy for intermediate age-related macular degeneration
This trial tests a new light-based treatment for intermediate age-related macular degeneration (AMD), a common eye condition that can lead to vision loss. The goal is to see if it is safe and helps slow down the disease.
BergamoAges 50 years+ - NCT06557668Recruiting
Immunomodulator plus cancer therapy for colorectal cancer
This study looks at how well a type of drug called an immunomodulator, given together with other cancer treatments, works for people with colorectal cancer. It aims to see if combining these therapies can improve outcomes.
TaichungAges 20 years+ - NCT06559345RecruitingPhase 2
Stem cell transplant study for children with ALL in remission
This trial tests a stem cell transplant using a half-matched family donor for children with acute lymphoblastic leukemia (ALL) that is in remission. It compares two different types of radiation conditioning to prepare the body for the new cells, with the goal of improving outcomes.
Zhengzhou, HenanAges 1–17 - NCT06559371Recruiting
PET scan to check lymph nodes after breast cancer treatment
This study uses a special PET scan (68Ga FAPI) to check if lymph nodes under the arm still have cancer after you finish pre-surgery treatment. It helps doctors see how well the treatment worked before you have surgery.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06559475Recruiting
Testing a new aspiration catheter for large vessel stroke
This trial tests a new catheter (Super-Bore 8/7F) to remove blood clots in people having a major stroke caused by a blocked large artery in the brain. The goal is to see if it is safe and effective at restoring blood flow when used within 24 hours of stroke symptoms starting.
Hefei, AnhuiAges 18 years+ - NCT06560372Recruiting
Bleeding after head injury and brain blood vessel narrowing
This study looks at whether moderate to severe traumatic brain injury with bleeding around the brain can lead to a complication called cerebral vasospasm (narrowing of brain blood vessels). It's being done at Martinique University Hospital to understand how often this happens and how it affects recovery.
Fort-de-FranceAges 18 years+ - NCT06560424Recruiting
Heart and metabolic health study
This trial collects samples and data to study cardiovascular and metabolic health. You may join if you are willing to participate and do not have severe chronic anemia.
Cleveland, OhioAges 18 years+ - NCT06562478Recruiting
Meditation after heart attack study
This study tests whether regular Zazen (a type of seated meditation) can help people recover better after a recent heart attack. You would attend meditation sessions at the hospital twice a week for several weeks.
Porto Alegre, Rio Grande do SulAges 18 years+ - NCT06562738RecruitingPhase 4
Hetrombopag for low platelets before surgery
This trial tests whether the drug hetrombopag can safely raise platelet counts in people with immune thrombocytopenia (ITP) before they have surgery. The goal is to reduce bleeding risk during and after the operation.
Chengdu, SichuanAges 18 years+ - NCT06564246RecruitingPhase 4
Comparing Vonoprazan vs. Pantoprazole for GERD
This trial tests a newer medication called vonoprazan against the standard treatment pantoprazole for patients with gastroesophageal reflux disease (GERD). The goal is to see which one works better for controlling symptoms like heartburn and acid reflux over 8 weeks.
GizaAges 17–60 - NCT06564493RecruitingPhase 2
Radiation conditioning before sibling stem cell transplant for pediatric ALL
This study tests two types of radiation-based conditioning (TBI or TMLI) before a stem cell transplant from a matched sibling donor, in children with ALL that is in remission. The goal is to see which approach works better and is safer.
Zhengzhou, HenanAges 1–17 - NCT06564545RecruitingPhase 2
Radiation-based transplant preparation for adult ALL
This trial studies a new way to prepare adults with ALL for a stem cell transplant from a half-matched family donor. It compares two types of radiation-based conditioning to see which works better and has fewer side effects.
Zhengzhou, HenanAges 18–65 - NCT06564805Recruiting
Steroid vs. yeast extract injection for patchy hair loss
This trial compares two injections—triamcinolone (a steroid) and candida albicans antigen (a yeast extract)—to see which works better for alopecia areata (patchy hair loss). You might benefit if you have mild to moderate hair loss and haven't used other treatments recently.
Monterrey, Nuevo LeónAges 6 years+
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,622 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.